Filters

See more specimen types...

Other countries

Results: 1 to 20 of 56

Tests names and labsConditionsGenes and analytesMethods

CentoICU platinum

Centogene AG - the Rare Disease Company
Germany
768514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
768514
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
4062
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Centogene AG - the Rare Disease Company
Germany
4688
  • E Sequence analysis of select exons

Myeloid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
3253
  • X Mutation scanning of select exons

Leukemia, juvenile myelomonocytic

Centogene AG - the Rare Disease Company
Germany
11
  • C Sequence analysis of the entire coding region

Rasopathies NGS Panel

Health in Code S.L.
Spain
2612
  • C Sequence analysis of the entire coding region

RASopathy Next Generation Sequencing and Deletion/Duplication

Medical Genomics Laboratory Department of Genetics, University of Alabama at Birmingham
United States
815
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Non-NF1 RASopathy Next Generation Sequencing and Deletion/Duplication

Medical Genomics Laboratory Department of Genetics, University of Alabama at Birmingham
United States
715
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Juvenile Myelomonocytic Leukemia

UCSF Molecular Diagnostics Laboratory University of California, San Francisco
United States
59
  • C Sequence analysis of the entire coding region

NOONAN SYNDROME

Genetic Diagnostics for Hereditary Cancer Unit Institute of Predictive and Personalized Medicine of Cancer IMPPC
Spain
510
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

RASOPATHY-RELATED SYNDROME

Genetic Diagnostics for Hereditary Cancer Unit Institute of Predictive and Personalized Medicine of Cancer IMPPC
Spain
913
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

PTPN11 Sequence Analysis (Prenatal Diagnosis)

Baylor Miraca Genetics Laboratories
United States
41
  • T Targeted variant analysis

PTPN11 Sequence Analysis (Familial Mutation/Variant Analysis)

Baylor Miraca Genetics Laboratories
United States
41
  • T Targeted variant analysis

PTPN11 Sequence Analysis

Baylor Miraca Genetics Laboratories
United States
41
  • C Sequence analysis of the entire coding region

Paraganglioma-Pheochromocytoma Comprehensive Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
37111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Sarcoma Comprehensive Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
92126
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Gastric Cancer Comprehensive Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
42514
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Comprehensive Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
51618
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Cancer Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
1736124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 56

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.